Peptides explained in plain language
Not medical advice
Research-only

Melanotan II and your skin: the case reports

Sold online as a "tanning injection," Melanotan II has never been approved, and doctors have published a string of worrying case reports.

Key takeaways

  • Melanotan II is not FDA-approved and isn't eligible for compounding in the U.S.
  • Published case reports link it to sudden mole changes, and some describe melanoma in users.
  • Other reports describe painful erections, muscle breakdown and kidney injury.
  • If you have used it and notice new or changing moles, see a dermatologist.

Melanotan II is a lab-made peptide that copies a natural hormone involved in skin color. It is sold online as a way to tan without the sun, and sometimes as a sexual stimulant. It is often nicknamed the “Barbie drug” or a “tanning jab.”

It has never been approved by the FDA. A nomination to let pharmacies compound it was withdrawn, so it isn’t eligible for compounding either. What you find online is typically sold “for research use only.” That means no one checks the dose, purity or sterility.

Why doctors pay attention to it

Melanotan II acts on melanocortin receptors. These receptors help control pigment in the skin, but they also affect appetite, blood vessels and sexual function. Because it isn’t selective, it can trigger effects well beyond a tan.

FDA has noted concerns that compounded Melanotan II could provoke immune reactions and has pointed to reports of serious adverse events, including melanoma.

What the case reports describe

A case report is a doctor’s write-up of what happened to one patient. It can’t prove that a drug caused a problem or show how often it happens. But when similar reports pile up, they are a warning sign worth taking seriously. Published reports about Melanotan II include:

  • Mole changes: doctors have described patients who developed new or unusual-looking moles soon after injections.
  • Melanoma: several reports describe melanoma, a serious skin cancer, in people who had used melanotan products.
  • Priapism: a painful erection that won’t go away and needs emergency care.
  • Muscle and kidney injury: reports describe severe muscle breakdown with kidney injury, and a blocked blood supply to the kidney.
  • Common complaints: nausea, flushing, headaches and dizziness also appear in the medical literature.
A darker tan can hide changes. Darkened skin and new spots can make it harder for you, or a doctor, to notice a mole that is changing.
Get the weekly peptide brief

What changed in the rules, what new research says, and which claims to ignore. One email a week.

How it differs from Vyleesi

Bremelanotide, sold as Vyleesi, is a related compound that is FDA-approved for one specific use in premenopausal women. It went through clinical trials and has a label that spells out its risks. Melanotan II has no approved use, no approved dose and no quality control when bought online.

If you have used it

  • Tell your doctor what you used and when.
  • Get a full skin check from a dermatologist, especially if you have many moles or a family history of melanoma.
  • Watch for moles that change in size, shape or color, or that bleed or itch.
  • Seek urgent care for an erection lasting more than four hours, dark urine, or severe muscle pain.

The bottom line

Melanotan II is an unapproved product with a growing list of case reports, many of them involving the skin. If you want a tan, a sunless tanning lotion carries far fewer unknowns. If you have used Melanotan II, a skin check is a sensible, simple next step.

This article is for general education and isn’t medical or legal advice. It was written with AI assistance and may contain errors, so check anything that matters against the sources above and with a qualified healthcare professional before starting, stopping or changing any treatment. Why we say this.

Chris Janowski
About the author

Chris Janowski, owner and editor in chief

Chris Janowski is the editor in chief of Peptide Consumer Center. He started the site to give people a plain-language, well-sourced place to learn what peptides are, how they’re regulated and what the evidence actually says. Articles are written with AI assistance and published under his name.

Peptide Consumer Center is owned by Chris Janowski, who also owns PureVitaX, an online store that sells peptides, including several covered on this site. We link to PureVitaX, and Chris benefits when you buy there. Disclosures.